A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer
© Balko and Black; licensee BioMed Central Ltd. 2009
Received: 28 January 2009
Accepted: 13 May 2009
Published: 13 May 2009
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|28 Jan 2009||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|2 Mar 2009||Reviewed||Reviewer Report - Pierre Laurent-Puig|
|12 Mar 2009||Reviewed||Reviewer Report - Igor Jurisica|
|2 Apr 2009||Author responded||Author comments - Esther Black|
|Resubmission - Version 3|
|2 Apr 2009||Submitted||Manuscript version 3|
|26 Apr 2009||Reviewed||Reviewer Report - Pierre Laurent-Puig|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|13 May 2009||Editorially accepted|
|13 May 2009||Article published||10.1186/1471-2407-9-145|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.